Zacks Research Has Negative Outlook for Exelon Q1 Earnings

Exelon Co. (NASDAQ:EXC - Free Report) - Equities researchers at Zacks Research decreased their Q1 2025 earnings per share estimates for shares of Exelon in a research note issued to investors on Tuesday, October 29th. Zacks Research analyst R. Department now forecasts that the company will post earnings per share of $0.71 for the quarter, down from their prior estimate of $0.75. The consensus estimate for Exelon's current full-year earnings is $2.44 per share. Zacks Research also issued estimates for Exelon's Q2 2026 earnings at $0.55 EPS.

Several other research analysts have also issued reports on EXC. UBS Group raised their target price on Exelon from $40.00 to $43.00 and gave the stock a "neutral" rating in a research report on Friday, September 20th. Barclays boosted their price objective on Exelon from $41.00 to $44.00 and gave the company an "overweight" rating in a research note on Tuesday, October 15th. Scotiabank boosted their target price on Exelon from $37.00 to $40.00 and gave the company a "sector perform" rating in a research report on Tuesday, August 20th. Jefferies Financial Group assumed coverage on Exelon in a research report on Thursday, September 19th. They issued a "buy" rating and a $46.00 target price for the company. Finally, Morgan Stanley boosted their price objective on Exelon from $42.00 to $45.00 and gave the stock an "equal weight" rating in a report on Wednesday, September 25th. Eleven equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company's stock. According to data from MarketBeat, the company presently has an average rating of "Hold" and a consensus price target of $41.33.

Exelon Trading Down 1.0 %

NASDAQ:EXC traded down $0.40 during trading hours on Thursday, hitting $39.30. 9,240,395 shares of the company were exchanged, compared to its average volume of 6,765,575. The stock has a market capitalization of $39.32 billion, a price-to-earnings ratio of 16.17, a price-to-earnings-growth ratio of 2.90 and a beta of 0.53. The company has a current ratio of 1.03, a quick ratio of 0.93 and a debt-to-equity ratio of 1.66. Exelon has a one year low of $33.35 and a one year high of $41.48. The company has a fifty day simple moving average of $39.65 and a 200 day simple moving average of $37.70.

Exelon (NASDAQ:EXC - Get Free Report) last announced its quarterly earnings results on Wednesday, October 30th. The company reported $0.71 EPS for the quarter, beating analysts' consensus estimates of $0.67 by $0.04. Exelon had a return on equity of 9.40% and a net margin of 10.65%. The company had revenue of $6.15 billion during the quarter, compared to analysts' expectations of $5.85 billion. During the same period in the prior year, the company earned $0.67 EPS. Exelon's revenue was up 2.9% compared to the same quarter last year.

Exelon Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 13th. Investors of record on Monday, November 11th will be paid a $0.38 dividend. The ex-dividend date of this dividend is Friday, November 8th. This represents a $1.52 annualized dividend and a yield of 3.87%. Exelon's payout ratio is 62.55%.

Hedge Funds Weigh In On Exelon

Several institutional investors have recently bought and sold shares of EXC. Crewe Advisors LLC purchased a new stake in shares of Exelon during the first quarter worth $26,000. Versant Capital Management Inc lifted its position in shares of Exelon by 646.2% during the second quarter. Versant Capital Management Inc now owns 776 shares of the company's stock worth $27,000 after acquiring an additional 672 shares in the last quarter. J.Safra Asset Management Corp purchased a new stake in shares of Exelon during the second quarter worth $28,000. American National Bank & Trust lifted its position in shares of Exelon by 178.8% during the third quarter. American National Bank & Trust now owns 697 shares of the company's stock worth $28,000 after acquiring an additional 447 shares in the last quarter. Finally, Abound Wealth Management lifted its position in shares of Exelon by 502.7% during the second quarter. Abound Wealth Management now owns 892 shares of the company's stock worth $31,000 after acquiring an additional 744 shares in the last quarter. Hedge funds and other institutional investors own 80.92% of the company's stock.

About Exelon

Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.